Click to view the official SEC document.

Reported Thursday, Aug 6 - 9:04am EDT (TheFly subscription required to read more.)

Reported Wednesday, Aug 5 - 4:05pm EDT (TheFly subscription required to read more.)

Reported Wednesday, Aug 5 - 4:05pm EDT (TheFly subscription required to read more.)

Cardlytics (NASDAQ: CDLX) reported second quarter 2026 revenue of $36.9 million, down 36% year-over-year, and Billings of $65.5 million, down 34%. Adjusted Contribution was $21.3 million (–32% YoY), and Net Loss widened to $(14.9) million. Adjusted EBITDA was $1.7 million, compared with $3.0 million a year earlier.Net loss per share from continuing operations was $(1.50) versus $(1.15), while Adjusted Net Loss per share was $(0.81) versus $(0.60). Operating cash flow was $(8.6) million and Free Cash Flow was $(10.7) million. MQUs declined 17% to 185.4 million, and ACPU fell to $0.11 from $0.14.For the third quarter 2026, Cardlytics expects Billings of $61–$67 million, Revenue of $34–$39 million, Adjusted Contribution of $20–$23 million, and Adjusted EBITDA between $0 and $3 million, all implying year-over-year declines.

Cardlytics (NASDAQ: CDLX) reported that on August 3, 2026 it granted an aggregate of 50,000 restricted stock units (RSUs) to its newly appointed Chief Legal Officer, Chris Cheng. According to Cardlytics, the award was approved as a material inducement to Cheng’s employment under Nasdaq Listing Rule 5635(c)(4) and issued pursuant to the company’s 2022 Inducement Plan.The RSUs will vest over 24 months: 25,000 shares are scheduled to vest on September 1, 2027, with the remaining 25,000 shares vesting quarterly over the following 12 months, in each case subject to Cheng’s continued service with Cardlytics through the applicable vesting dates.

Reported Friday, Jul 31 - 8:34am EDT (TheFly subscription required to read more.)

Cardlytics (NASDAQ: CDLX) reported that on July 29, 2026, its Board’s Compensation Committee granted an aggregate of 10,320 restricted stock units (RSUs) to 10 newly hired employees. The awards were issued as material inducements to employment under Nasdaq Listing Rule 5635(c)(4) and made pursuant to the 2022 Inducement Plan.According to Cardlytics, for each recipient, 50% of the RSUs vest on the first anniversary of the grant date, with the remaining 50% vesting quarterly over the following 12 months, subject to continuous service and the terms of the 2022 Inducement Plan.

Reported Wednesday, Jul 29 - 8:33am EDT (TheFly subscription required to read more.)

Cardlytics (NASDAQ: CDLX) announced the appointment of Chris Cheng as Chief Legal Officer, effective August 3, 2026. He will join the Leadership Team and lead the Legal and Compliance organization. Cheng succeeds former Chief Legal Officer Nick Lynton, who departed in July 2026.According to Cardlytics, Cheng brings over 20 years of legal leadership at high‑growth technology and public companies, including senior roles at Zoom, Uber, Upwork, eBay, and most recently as Chief Legal Officer and Corporate Secretary at Iterable.

Reported Friday, Jun 5 - 7:50pm EDT (TheFly subscription required to read more.)

Click to view the official SEC document.

Click to view the official SEC document.

Reported Friday, May 8 - 8:53am EDT (TheFly subscription required to read more.)

Reported Thursday, May 7 - 4:12pm EDT (TheFly subscription required to read more.)

Cardlytics (NASDAQ: CDLX) reported Q1 2026 results: Revenue $34.3M, Billings $58.1M, and Adjusted Contribution $19.7M. The company completed the Bridg divestiture on March 24, 2026 and liquidated PAR shares to strengthen the balance sheet. Adjusted EBITDA turned positive to $0.2M and net loss narrowed to $4.5M. Q2 2026 guidance: Billings $61.0–$67.0M; Revenue $35.0–$40.0M; Adjusted Contribution $20.0–$23.0M.

Cardlytics (NASDAQ:CDLX) Stock Price Down 3.1% - Here's What Happened

Cardlytics CEO Raj Gupta sold $118,000 of CDLX on Apr 2, 2026 (Investing.com); Form 4 disclosure is required within two business days under SEC rules.

Cardlytics (NASDAQ: CDLX) completed the sale of its Bridg assets to PAR Technology (NYSE: PAR) on March 24, 2026, receiving 1,810,222 shares of PAR common stock as consideration.Cardlytics said it will strategically monetize the PAR position to pay down a majority of its line of credit, strengthen the balance sheet, and refocus on scaling its core Cardlytics platform; Bridg employees and operations transferred to PAR.

Reported Friday, Mar 6 - 8:51am EST (TheFly subscription required to read more.)

Reported Thursday, Mar 5 - 8:44am EST (TheFly subscription required to read more.)